A major scientific breakthrough could transform the future of pancreatic cancer treatment. Researchers say they have achieved what they describe as the “permanent disappearance” of the disease in laboratory tests, using a novel triple-drug therapy approach.
For decades, pancreatic cancer has been one of the deadliest forms of cancer, known for spreading quickly and resisting most available treatments.
Now, scientists have developed a three-drug combination that attacks the disease from multiple angles.
The therapy works by blocking three key “survival routes” that cancer cells use to grow, spread, and resist medication.
The research, led by Spanish biochemist Dr. Mariano Barbacid, tested the treatment on three different mouse models.
These included genetically engineered mice born with pancreatic cancer-causing genes, mice implanted with human pancreatic tumor tissue, and mice that had pancreatic cancer cells surgically introduced into their pancreas.
Results showed a dramatic reduction in tumor growth, with some cases showing a complete disappearance of the disease.
Despite the promising findings, researchers urge caution. Dr Barbacid emphasized that the treatment is not yet ready for human trials.
He explained that more work is needed to optimize the drug combination and ensure safety, noting that success in animal studies does not always translate to humans.
Still, scientists say the breakthrough offers renewed hope in the fight against one of the world’s most aggressive cancers.
If future clinical trials prove successful, the triple-drug approach could mark a major turning point in pancreatic cancer treatment.
